North China Pharmaceutical Company. Ltd. provided earnings guidance for the year of 2018. For the period, the company predicts that the net profit belonging to shareholders will be about RMB 152 million with an increase of about RMB 133.24 million compared with the same period of the year before, with a year-on-year increase of about 710.25%. The net profit belonging to shareholders excluding extraordinary profit and loss will be RMB 22 million with an increase of about RMB 50,000 and an increase of about 0.23% compared with the same period of the year before.